Back to results
US 2006/0040900 A1Published application
R(-)-11-hydroxyaporphine derivatives and uses thereof
AssigneeThe McLean Hospital Corporation
InventorsJohn Neumeyer, Ross Baldessarini
Life of this patent
Estimating the term…
Abstract
The invention features derivatives of R(—)-11-hydroxyaporphines and methods of treating Parkinson's disease, sexual dysfunction, and depressive disorders therewith.
Claims25
A compound of formula I:
- or a pharmaceutically acceptable salt or solvate thereof,
- wherein
- Y1, is C(O)—R3, C(O)—O—R3, C(O)—NR3R4, P(O)(OH)—O—R3, C(S)—R3, C(S)—O—R3,
- C(S)—NR3R4, or fatty acid acyl;
- X1 is H, F, Cl, Br, I, OH, OCH3, or OC(O)—R5;
- R1 is H, C1-4 alkyl, C2-4 alkenyl, or C2-4 alkynyl;
- R2 is H, CH3, or OCH3;
- each of R3 and R4 is, independently, selected from H, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C2-6 heterocyclyl, C6-12 aryl, C7-14 alkaryl, C3-10 alkheterocyclyl, and C1-7 heteroalkyl, or R3 and R4 together form a heterocyclic ring containing at least one nitrogen atom;
- and
- R5 is c1-4 alkyl, c2-4 alkenyl, or c2-4 alkynyl.
7 more elements
A compound of formula IV:
- or a pharmaceutically acceptable salt or solvate thereof,
- wherein
- X2 is F, Cl, Br, I, OH, OCH3, or OC(O)—R13;
- R11 is H, C1-4 alkyl, C2-4 alkenyl, or C2-4 alkynyl;
- R12 is H, CH3, or OCH3;
- and
- R13 is C1-4 alkyl, C2-4 alkenyl, or C2-4 alkynyl.
4 more elements
Dependencies are inferred from the claim text.